July 20, 2017 1:18 PM ET

Biotechnology

Company Overview of Progen Pharmaceuticals, Inc.

Key Executives for Progen Pharmaceuticals, Inc.

NameBoard RelationshipsTitleAge
Thomas D. Kiley Esq.16 RelationshipsCo-Founder and Director74

Progen Pharmaceuticals, Inc. Board Members*

NameBoard RelationshipsPrimary CompanyAge
Thomas D. Kiley Esq. 16 RelationshipsProgen Pharmaceuticals, Inc.74
Michael G. Raab 28 RelationshipsArdelyx, Inc.52
Anthony E. Pegg Ph.D. 6 RelationshipsProgen Pharmaceuticals, Inc.--
Randall K. Johnson Ph.D. 77 RelationshipsTetraLogic Pharmaceuticals Corporation70
Daniel Douglas Von Hoff M.D., F.A.C.P. 472 RelationshipsOncology Venture Sweden AB69
View All Board Members

Progen Pharmaceuticals, Inc. Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
There is no committee data available.
*Data is at least as current as the most recent Definitive Proxy.
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

CEO COMPENSATION IN THIS INDUSTRY

  Industry Range
Salary
389.8K
Bonus
235.7K
Total Short Term Compensation
484.0K
Total Value of Options
18.1M
Compensation as of Fiscal Year
Progen Pharmaceuticals, Inc. CEO Compensation
Industry Average

INDUSTRY EXECUTIVE CHANGES

Myovant Sciences Ltd. Announces Management Appointments
July 19, 2017 8:05 PM ET
Quest PharmaTech Announces Board Changes
July 19, 2017 1:55 PM ET
Paul Harper to Step Down as Non-Executive Director of Reneuron Group plc
July 19, 2017 6:00 AM ET
Medibio Limited Appoints Adam Darkins to the Board of Directors as Deputy Chairman
July 19, 2017 2:52 AM ET
SenzaGen Announces Executive Appointments
July 18, 2017 5:45 PM ET

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Progen Pharmaceuticals, Inc., please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.